[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use ZapMax, a product promoted and sold for sexual enhancement on various websites, including […]

[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use VitalityXtra, a product promoted and sold for sexual enhancement on various websites, including […]

[11-19-2024] The Food and Drug Administration is advising consumers not to purchase or use HON-E-LING, a product promoted for sexual enhancement on various websites, and possibly in […]

[10-30-2024] The Food and Drug Administration is advising consumers not to purchase or use OneMultivitaminic GAF-Plus Advance, a product promoted and sold for pain on various […]

[11/30/2022] The U.S. Food and Drug Administration today announced bebtelovimab is not currently authorized for emergency use in the U.S. because it is not expected to neutralize […]

FDA has revoked the Emergency Use Authorization for bebtelovimab. For more information, see FDA’s webpage for archived EUAs. ][November 30, 2022] FDA announced bebtelovimab is not […]

Update [4/5/2022] Sotrovimab is no longer authorized to treat COVID-19 in any U.S. region due to increases in the proportion of COVID-19 cases caused by the […]

FDA has revoked the Emergency Use Authorization for bamlanivimab administered alone, bamlanivimab and etesevimab administered together, and REGEN-COV. For more information, see FDA’s webpage for archived […]

For Immediate Release: December 23, 2024 Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like […]